ENOV (46) ESTA (34) AVR (36) SMTI (57) ⌘ Pro Terminal →

Cadre Holdings Inc. (CDRE) — RQD Stock Rating Cockpit

$31.10 +3.81% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Cadre Holdings Inc. (CDRE) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (43% profit margin, 11% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $1.33B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CDRE)Realized 20D OHLCV Swing Band: ±9%

RSI-14 MOMENTUMBULLISH MOMENTUM

6530 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.32>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

9 / 99-Pt Accounting

52-WEEK LASER RANGE28% OF RANGE

L: $24$31.10H: $49

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (43% profit margin and healthy balance-sheet cushion).

Factor Grade: B+RQD 16 / 20

2. Big Money & Insiders● BUYING

Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: B-RQD 28 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: BRQD 30 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bullish on CDRE

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (80)

11.0% ROIC with 42.5% gross margin and 4.27% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (75)

Altman-Z 3.32 and Piotroski 9/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (72)

28/40 institutional & smart-money positioning score with 15/20 macro alignment.

Bull Case: Why Buyers Like CDRE

✓Strong cash generator (43% profit margin)—profits are backed by real money, not accounting tricks.
✓Company leadership has skin in the game with net positive insider conviction.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Broader market pullbacks can still drag down strong stocks in the short run.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (CDRE Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CDRE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +4.89%📐 HORIZONTAL RANGE

2026-10-30O $31.14H $31.49L $30.03C $31.10VOL 320.5K

RES: $42.91SUP: $22.98SMA50: $27.96SMA200: $32.22

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CDRE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CDRE Butterfly Map → + Track CDRE →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

23.3%/yr Implied 5Y Growth

vs. +7.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CDRE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CDRE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CDRE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CDRE)

Health Care Rank #55 of 1016 ⚔️ ENOV vs CDRE Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CDRE vs. ENOV, ESTA, AVR, SMTI)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Cadre Holdings Inc. (CDRE) ranks #55 by composite RQD confidence (74/100, grade B) and #323 by equity capitalization ($1.33B). Within this direct 5-issuer industry benchmark cohort, SMTI leads on earnings valuation at 8.1x trailing P/E, while SMTI leads on capital efficiency and profitability with 16.3% ROIC and 92.7% gross margin. CDRE currently leads its immediate peer cohort in composite quantitative strength at 74/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CDRE ACTIVE Cadre Holdings Inc.	B	74/100	30.2x	42.5%	11.0%	+3.81%	$1.33B	Benchmark Subject
ENOV Enovis Corporation	D	46/100	—	59.8%	-32.7%	+4.11%	$1.32B	/enov-vs-cdre →
ESTA Establishment Labs Holdings Inc.	E	34/100	—	69.3%	-15.8%	-0.81%	$2.04B	/esta-vs-cdre →
AVR Anteris Technologies Global Corp.	D-	36/100	—	70.3%	-35.0%	+5.25%	$625.9M	/avr-vs-cdre →
SMTI Sanara MedTech Inc.	D+	57/100	8.1x	92.7%	16.3%	+0.11%	$302.4M	/smti-vs-cdre →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001860543

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cadre Holdings Inc. (CDRE) reported GAAP revenue of $610.3M (+7.5% vs. FY2024 revenue of $567.6M , and +26.5% cumulative change since FY2023) , GAAP net income of $44.1M, operating cash flow of $63.7M, and free cash flow of $56.8M (+117.7% YoY). On the balance sheet, CDRE closed FY2025 with $770.0M in total assets against $291.0M in total debt (Altman Z-Score: 3.32, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$610.3M	$44.1M	$63.7M	$56.8M	$770.0M	$291.0M
FY2024 (FY)	2024-12-31	$567.6M	$36.1M	$31.8M	$26.1M	$652.7M	$211.8M
FY2023 (FY)	2023-12-31	$482.5M	$38.6M	$73.2M	$73.2M	—	—

3. CDRE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CDRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Cadre Holdings Inc. (NYSE: CDRE) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $31.10 (+3.81% 1D, market cap $1.33B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, CDRE ranks #55 in composite RQD confidence.

How does CDRE compare to ENOV and ESTA in the Health Care sector?

Within the Health Care sector (Industrial Specialties), CDRE carries a Roarable B (74/100 RQD), trailing P/E of 30.2x, gross margin of 42.5%, and ROIC of 11.0%. By comparison, ENOV (Enovis Corporation) holds a D grade (46/100 RQD, P/E N/A, ROIC -32.7%, cap $1.32B) and ESTA (Establishment Labs Holdings Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -15.8%, cap $2.04B). Among the 5-stock peer group, SMTI leads on earnings multiple (8.1x) while SMTI leads on capital efficiency (16.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CDRE?

Per CDRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001860543), Cadre Holdings Inc. generated $610.3M in revenue (+7.5% YoY), $44.1M in net income, and $56.8M in free cash flow against $770.0M in total assets and $291.0M in total debt. Key quantitative strengths: Strong cash generator (43% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CDRE trading relative to its 50-day, 200-day, and 52-week technical levels?

CDRE last traded at $31.10 (+3.81% on volume of 433,055 shares), positioning the stock +11.23% above its 50-day simple moving average ($27.96) and -3.48% below its 200-day simple moving average ($32.22). Across its 52-week range of $24.07 to $48.76, CDRE sits at the 28.5% percentile with a 14-day RSI of 65.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±9.0% ($28.30 to $33.90).

CDRE Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell CDRE stock right now?

Cadre Holdings Inc. (CDRE) currently earns a Roarable Rating of B (Buy — BUY) with 74/100 RQD Confidence. High-quality cash engine (43% profit margin, 11% return on capital) with steady institutional support.

What is CDRE's 12-month price target and RQD AI Jury consensus?

CDRE's 12-month base price target is $33.34 (range $25.5 to $51.2), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: CDRE RQD Cockpit CDRE 12M Forecast CDRE Earnings & Move CDRE Dividends & DRIP CDRE Insiders & 13F CDRE Whale Options CDRE Profit Sankey CDRE News & Why